ALDX
Aldeyra Therapeutics, Inc.
0.9586$
+4.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 127.5% | – | – | – | -4,922.5% | – | – | – | – | – | – | – | |
| – | 16.9% | – | – | – | 26.3% | – | – | – | – | – | – | – | |
| – | -203.8% | – | – | – | 516.6% | – | – | – | – | – | – | – | |
| – | 1,506.9% | – | – | – | 1,171.9% | – | – | – | – | – | – | – | |
| – | 0.0% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -639.6% | – | – | – | – | – | – | – | |
| – | 265.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -257.8% | – | – | – | 3.2% | – | – | – | – | – | – | – | |
| – | -130.4% | – | – | – | -5,558.9% | – | – | – | – | – | – | – | |
| – | 127.5% | – | – | – | -4,922.5% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.